We recently demonstrated that VLDL secretion is reduced in the absence of StarD5, likely contributing to the increased liver triglyceride content in StarD5−/− mice, making StarD5−/− mice more prone to developing steatosis and fibrosis [18]. Here, STARD5 is linked to steatosis.